New Risk • Jun 29
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Romanian stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 33% per year over the past 5 years. Revenue is less than US$1m (RON470k revenue, or US$102k). Market cap is less than US$10m (RON26.9m market cap, or US$5.85m). Minor Risk Share price has been volatile over the past 3 months (7.3% average weekly change). Announcement • Jun 01
Sinteza S.A. to Report Q3, 2026 Results on Nov 17, 2026 Sinteza S.A. announced that they will report Q3, 2026 results on Nov 17, 2026 Reported Earnings • May 31
First quarter 2026 earnings released First quarter 2026 results: Net loss: RON1.61m (loss narrowed 12% from 1Q 2025). New Risk • May 02
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Romanian stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 34% per year over the past 5 years. Revenue is less than US$1m (RON391k revenue, or US$88k). Market cap is less than US$10m (RON36.4m market cap, or US$8.19m). Minor Risk Share price has been volatile over the past 3 months (6.5% average weekly change). Reported Earnings • Apr 29
Full year 2025 earnings released Full year 2025 results: Net loss: RON3.44m (loss narrowed 61% from FY 2024). Announcement • Apr 26
Sinteza S.A. to Report Fiscal Year 2025 Results on Apr 23, 2026 Sinteza S.A. announced that they will report fiscal year 2025 results on Apr 23, 2026 Reported Earnings • Mar 02
Full year 2025 earnings released Full year 2025 results: Net loss: RON3.44m (loss narrowed 61% from FY 2024). New Risk • Dec 02
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Romanian stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 33% per year over the past 5 years. Revenue is less than US$1m (RON460k revenue, or US$105k). Market cap is less than US$10m (RON43.3m market cap, or US$9.88m). Minor Risk Share price has been volatile over the past 3 months (7.7% average weekly change). Reported Earnings • Nov 20
Third quarter 2025 earnings released Third quarter 2025 results: Net income: RON732.7k (up RON2.11m from 3Q 2024). New Risk • Oct 10
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: RON43.6m (US$9.95m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 31% per year over the past 5 years. Revenue is less than US$1m (RON566k revenue, or US$129k). Market cap is less than US$10m (RON43.6m market cap, or US$9.95m). Reported Earnings • Sep 01
Second quarter 2025 earnings released Second quarter 2025 results: Net loss: RON1.89m (loss widened 56% from 2Q 2024). Buy Or Sell Opportunity • Jul 10
Now 20% overvalued Over the last 90 days, the stock has fallen 64% to RON0.79. The fair value is estimated to be RON0.65, however this is not to be taken as a sell recommendation but rather should be used as a guide only. New Risk • May 31
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: RON39.7m (US$8.90m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Earnings have declined by 26% per year over the past 5 years. Revenue is less than US$1m (RON680k revenue, or US$153k). Market cap is less than US$10m (RON39.7m market cap, or US$8.90m). Reported Earnings • May 02
Full year 2024 earnings released Full year 2024 results: Net loss: RON6.75m (loss narrowed 37% from FY 2023). New Risk • Mar 13
New major risk - Revenue size The company makes less than US$1m in revenue. Total revenue: RON2.8m (US$601k) This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (25% average weekly change). Earnings have declined by 24% per year over the past 5 years. Revenue is less than US$1m (RON2.8m revenue, or US$601k). Minor Risk Market cap is less than US$100m (RON154.7m market cap, or US$33.7m). Reported Earnings • Mar 05
Full year 2024 earnings released Full year 2024 results: Net loss: RON6.75m (loss narrowed 37% from FY 2023). Reported Earnings • Nov 17
Third quarter 2024 earnings released Third quarter 2024 results: Revenue: RON631.7k (down 81% from 3Q 2023). Net loss: RON1.38m (loss widened 16% from 3Q 2023). Buy Or Sell Opportunity • Nov 05
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 5.2% to RON0.25. The fair value is estimated to be RON0.32, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Buy Or Sell Opportunity • Oct 21
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 6.7% to RON0.25. The fair value is estimated to be RON0.32, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Buy Or Sell Opportunity • Oct 04
Now 26% undervalued after recent price drop Over the last 90 days, the stock has fallen 6.3% to RON0.24. The fair value is estimated to be RON0.32, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Buy Or Sell Opportunity • Sep 16
Now 28% undervalued after recent price drop Over the last 90 days, the stock has fallen 8.7% to RON0.23. The fair value is estimated to be RON0.32, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Reported Earnings • Sep 03
Second quarter 2024 earnings released Second quarter 2024 results: Revenue: RON655.5k (down 86% from 2Q 2023). Net loss: RON1.22m (loss narrowed 43% from 2Q 2023). Reported Earnings • May 19
First quarter 2024 earnings released First quarter 2024 results: Revenue: RON2.19m (down 40% from 1Q 2023). Net loss: RON2.74m (loss widened 67% from 1Q 2023). New Risk • Apr 09
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Romanian stocks, typically moving 9.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.3% average weekly change). Market cap is less than US$10m (RON16.9m market cap, or US$3.70m). Minor Risks Less than 1 year of cash runway based on current free cash flow (-RON2.5m). Revenue is less than US$5m (RON15m revenue, or US$3.2m). Reported Earnings • Mar 03
Full year 2023 earnings released Full year 2023 results: Revenue: RON18.1m (down 53% from FY 2022). Net loss: RON10.7m (loss widened 411% from FY 2022). Reported Earnings • Sep 03
Second quarter 2023 earnings released Second quarter 2023 results: Revenue: RON5.04m (down 48% from 2Q 2022). Net loss: RON2.13m (loss widened RON2.11m from 2Q 2022). Board Change • Jun 12
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • May 21
First quarter 2023 earnings released First quarter 2023 results: Revenue: RON3.64m (down 77% from 1Q 2022). Net loss: RON1.64m (down 181% from profit in 1Q 2022). Board Change • Nov 17
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Buying Opportunity • Sep 27
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 14%. The fair value is estimated to be RON0.42, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Buying Opportunity • May 04
Now 24% undervalued after recent price drop Over the last 90 days, the stock is down 4.6%. The fair value is estimated to be RON0.49, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Board Change • Apr 29
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Buying Opportunity • Apr 04
Now 27% undervalued after recent price drop Over the last 90 days, the stock is down 14%. The fair value is estimated to be RON0.49, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Reported Earnings • Mar 04
Full year 2021 earnings: Revenues in line with analyst expectations Full year 2021 results: Revenue: RON43.3m (up 97% from FY 2020). Net income: RON1.26m (up RON6.48m from FY 2020). Profit margin: 2.9% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Reported Earnings • Sep 04
Second quarter 2021 earnings released The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: RON10.9m (up 83% from 2Q 2020). Net income: RON780.2k (up RON1.31m from 2Q 2020). Profit margin: 7.1% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Board Change • Sep 01
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Apr 29
Full year 2020 earnings released The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: RON22.0m (down 2.3% from FY 2019). Net loss: RON5.23m (loss widened 27% from FY 2019). 
